Impressively, for doxorubicin-induced senescent breast tumor cell line MDA-MB-231, Rh2 not only suppressed the accepted p38MAPK and NF-κB pathways but also prohibited Stat3 pathway. The gene discussed is NFKB1; the disease is breast neoplasm.